Prevalence of Interstitial Lung Disease presented to Pulmonology department at Lady Reading Hospital Peshawar; Unrevealing the Burden
Keywords:
Connective Tissue Disease, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, PrevalenceAbstract
Background: Interstitial lung disease is a disabling pulmonary morbidity that results in irreversible damage to the lung parenchyma, leading to eventual dependence. This condition has a wide variety of subtypes, with their prevalence varying across different geographical regions of the world. Objective: To determine the prevalence of interstitial lung disease and its subtypes in patients presenting at Lady Reading Hospital, Peshawar. Methodology: This retrospective observational study was conducted at the Pulmonology Department, Lady Reading Hospital, Peshawar, from January to December 2023, in which 303 patients were screened for the presence of interstitial lung disease through a high-resolution computed tomography (HRCT) scan of the chest. Detailed history records and a comprehensive HRCT report by the radiologist were obtained and retrieved to determine sub-types. The data was analyzed by SPSS 20.00. Results: In this study, a total of 303 patients were included, with a mean age of 50.08 ± 7.56 years. There were 128 (42.24%) male and 175 (57.76%) female patients. All patients had complaints of coughing. The prevalence of interstitial lung disease was 136 (44.88%), with idiopathic pulmonary fibrosis being the most common subtype with a prevalence of 37 (27.21%), followed by “cryptogenic organizing pneumonia (COP)†(21 (15.44%), “hypersensitivity pneumonitis (HSP)" (20 (14.71%), sarcoidosis (19 (13.97%), “non-specific interstitial pneumonia (NSIP)†(14 (10.29%), “pulmonary alveolar proteinosis (PAP)†(9.56%), and “connective tissue disease-related ILD†12 (8.82%). Conclusion: The prevalence of interstitial lung disease was 44.88%, with idiopathic pulmonary fibrosis being the most common subtype.References
Maher TM. Interstitial lung disease: A review. JAMA. 2024. DOI: 10.1001/jama.2024.3669.
Constantino K, Gottlieb M, Long B. Interstitial lung disease: A focused review for the emergency clinician. J Emerg Med. 2023;64(2):156-166. DOI: 10.1016/j.jemermed.2022.10.015.
McCarthy C, Keane MP. Contemporary concise review 2021: Interstitial lung disease. Respirology. 2022;27(7):539-548. DOI: 10.1111/resp.14278.
Rezaee M, Azizi N, Danaei B, Davari A, Nejadghaderi SA, Sarmastzadeh T, et al. TB and interstitial lung disease: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2024;28(3):130-135. DOI: 10.5588/ijtld.23.0428.
Choi WI, Dauti S, Kim HJ, Park SH, Park JS, Lee CW. Risk factors for interstitial lung disease: a 9-year Nationwide population-based study. BMC Pulm Med. 2018;18(1):96. DOI: 10.1186/s12890-018-0660-2.
Smith DJF, Jenkins RG. Contemporary concise review 2022: Interstitial lung disease. Respirology. 2023;28(7):627-635. https://doi.org/10.1111/resp.14511.
Shah Gupta R, Koteci A, Morgan A, George PM, Quint JK. Incidence and prevalence of interstitial lung diseases worldwide: a systematic literature review. BMJ Open Respir Res. 2023;10(1):e001291. DOI: 10.1136/bmjresp-2022-001291.
Cottin V, Valenzuela C. Diagnostic approach of fibrosing interstitial lung diseases of unknown origin. Presse Med. 2020;49(2):104021. DOI: 10.1016/j.lpm.2020.104021.
Glenn LM, Troy LK, Corte TJ. Diagnosing interstitial lung disease by multidisciplinary discussion: A review. Front Med (Lausanne). 2022;9:1017501. DOI: 10.3389/fmed.2022.1017501.
Zubairi ABS, Ansarie M, Mahmud T, Ashraf S, Rao NA, Javaid A, et al. National Registry of Interstitial Lung Disease from Pakistan. Cureus. 2021 Apr 25;13(4):e14684. DOI: 10.7759/cureus.14684.
Anjum H, Ahmad H, Rehman M, Gul H. Prevalence of ILD subtypes on the basis of HRCT at a tertiary care hospital. Pak J Radiol. 2019;29(4):234-238.
Sarwar Zubairi AB, Hassan M, Shahzad T, Sarwar S, Abbas A, Ahmad H, et al. Spectrum of interstitial lung disease from a tertiary care hospital in Karachi. J Pak Med Assoc. 2017;67(7):1065-1069.
Alrajhi NN. Post-COVID-19 pulmonary fibrosis: An ongoing concern. Ann Thorac Med. 2023;18(4):173-181. DOI: 10.4103/atm.atm_7_23.
Bazdyrev E, Rusina P, Panova M, Novikov F, Grishagin I, Nebolsin V. Lung fibrosis after COVID-19: Treatment prospects. Pharmaceuticals (Basel). 2021;14(8):807. DOI: 10.3390/ph14080807.
Valenzuela C, Waterer G, Raghu G. Interstitial lung disease before and after COVID-19: a double threat? Eur Respir J. 2021;58(6):2101956. DOI: 10.1183/13993003.01956-2021.
Sanders JL, Putman RK, Dupuis J, Xu H, Murabito JM, Araki T, et al. The association of aging biomarkers, interstitial lung abnormalities, and mortality. Am J Respir Crit Care Med. 2021;203(9):1149-1157. DOI: 10.1164/rccm.202007-2993OC.
Verduri A, Carter B, Rice C, Laraman J, Barton E, Clini E, et al. Frailty prevalence and association with clinical outcomes in interstitial lung disease, asthma, and pleural disease. Geriatrics (Basel). 2023;8(4):82. DOI: 10.3390/geriatrics8040082.
Kawano-Dourado L, Glassberg MK, Assayag D, Borie R, Johannson KA. Sex and gender in interstitial lung diseases. Eur Respir Rev. 2021;30(162):210105. DOI: 10.1183/16000617.0105-2021.
Cottin V, Gueguen S, Jouneau S, Nunes H, Crestani B, Bonniaud P, et al.; OrphaLung and RespiFil Networks. Impact of gender on the characteristics of patients with idiopathic pulmonary fibrosis included in the RaDiCo-ILD cohort. Respiration. 2022;101(1):34-45. DOI: 10.1159/000518008.
Ozaki M, Glasgow A, Oglesby IK, Ng WL, Kelly S, Greene CM, et al. Sexual dimorphism in interstitial lung disease. Biomedicines. 2022;10(12):3030. DOI: 10.3390/biomedicines10123030.
Serrano Gotarredona MP, Navarro Herrero S, Gómez Izquierdo L, RodrÃguez Portal JA. Smoking-related interstitial lung disease. Radiologia (Engl Ed). 2022;64(Suppl_3):277-289. DOI: 10.1016/j.rxeng.2022.10.008.
Jafri S, Ahmed N, Saifullah N, Musheer M. Epidemiology and clinico-radiological features of Interstitial Lung Diseases. Pak J Med Sci. 2020;36(3):365-370. DOI: 10.12669/pjms.36.3.1046.
Dhooria S, Sehgal IS, Agarwal R, Muthu V, Prasad KT, Kathirvel S, et al. Incidence, prevalence, and national burden of interstitial lung diseases in India: Estimates from two studies of 3089 subjects. PLoS One. 2022;17(7):e0271665. DOI: 10.1371/journal.pone.0271665.
Laz NI, Mohammad MF, Srour MM, Arafat WR. Study of the prevalence and predictive factors of sleep-disordered breathing in patients with interstitial lung diseases. Egypt J Bronchol. 2024;18:11. DOI: 10.1186/s43168-024-00264-3
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Pakistan Journal of Chest Medicine

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


